Conference MiCRObiota Incognita

From September 26th – 28th 2016, Alfonso Benítez-Páez (IATA-CSIC, Spain) presents at Conference MiCRObiota Incognita (Island Krk, Croatia). The conference MiCRObiota Incognita is organised by Biodinamik to educate young scientists about new improvements and innovations in the Microbiome field and motivate them to resolve open questions.

Alfonso’s presentation will discuss MyNewGut and the role of gut microbes as potential therapy against diet-related diseases. 


Abstract: "Emerging evidence suggests the microbiome and its genome (microbiome) contributes to regulating energy balance and brain development and function, thereby determining our risk of developing diet and behavioural disorders. The MyNewGut project, which receives funding from the European Union’s 7th FP, will work towards identifying the influence of modifiable lifestyle factors on the gut microbiome and the specific intestinal bacteria that contribute to and predict these disorders at critical stages in life. Obesity is one of the major diet-related disorders to be investigated by the MyNewGut consortium. Obesity is a multifactorial disorder involving lifestyle factors such as diet, eating habits and physical activity, all set within a socio-cultural environment, as well as endogenous factors such as  genetics/epigenetics and neural, immune and endocrine functions. To progress in the understanding of the microbiota role within this complex scenario, the MyNewGut consortium will work to (1) expand knowledge of the contribution of the human microbiome and specific bacteria to nutrient metabolism and energy balance; (2)  identify microbiome-related features that contribute to or predict obesity and associated disorders and (3) provide proof-of-concept of the potential of dietary interventions with new foods/ingredients to reduce risk of obesity and the associated disorders in humans. To do so, we will develop a multidisciplinary research approach, using functional omics-technologies and systems biology, in well-controlled human trials. As a result, the MyNewGut project will generate robust scientific knowledge in human microbiome research, which will help to establish new strategies to ultimately reduce the socio-economic burden of diet-related disorders in the EU."